Martine Rothblatt Insider Trading Activity
Martine Rothblatt has been net-selling over the last 12 months with 1 purchase and 1080 sales across 1 company.
UTHR is the most-traded position with 1081 trades. The largest single transaction was a sale of UTHR for $2.5M on Jul 30, 2026.
Performance Scorecard
Forward stock performance after each transaction by Martine Rothblatt. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | -5.7% | -1.9% | 53% | 1056 |
| 90 days | -11.0% | +0.5% | 54% | 921 |
| 120 days | -15.0% | +1.3% | 58% | 885 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersUTHR ยท UNITED THERAPEUTICS Corp
๐ Subscribe to see trade entries
Pro members see exactly when Martine Rothblatt bought and sold UTHR.
Upgrade to ProRecent Trades
Showing the 50 most recent of 1,154 disclosed trades.
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | ฮ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Oct 21, 2026 | UTHR | Sell | 768 | $564.63 | $434K | โ0.2% | CEO | |
Oct 21, 2026 | UTHR | Sell | 1,253 | $563.43 | $706K | โ0.4% | CEO | |
Oct 21, 2026 | UTHR | Sell | 960 | $562.54 | $540K | โ0.3% | CEO | |
Oct 21, 2026 | UTHR | Sell | 200 | $561.44 | $112K | โ0.1% | CEO | |
Oct 21, 2026 | UTHR | Sell | 820 | $560.50 | $460K | โ0.2% | CEO | |
Oct 21, 2026 | UTHR | Sell | 743 | $559.25 | $416K | โ0.2% | CEO | |
Oct 21, 2026 | UTHR | Sell | 1,137 | $558.32 | $635K | โ0.3% | CEO | |
Oct 21, 2026 | UTHR | Sell | 1,702 | $557.25 | $948K | โ0.5% | CEO | |
Oct 21, 2026 | UTHR | Sell | 567 | $556.41 | $315K | โ0.2% | CEO | |
Oct 21, 2026 | UTHR | Sell | 550 | $555.19 | $305K | โ0.2% | CEO | |
Oct 21, 2026 | UTHR | Sell | 194 | $553.78 | $107K | โ0.1% | CEO | |
Oct 21, 2026 | UTHR | Sell | 46 | $552.52 | $25K | โ0.0% | CEO | |
Oct 21, 2026 | UTHR | Sell | 80 | $566.43 | $45K | โ0.0% | CEO | |
Oct 21, 2026 | UTHR | Sell | 480 | $565.36 | $271K | โ0.1% | CEO | |
Oct 20, 2026 | UTHR | Sell | 948 | $548.95 | $520K | โ0.3% | CEO | |
Oct 20, 2026 | UTHR | Sell | 575 | $547.79 | $315K | โ0.2% | CEO | |
Oct 20, 2026 | UTHR | Sell | 440 | $556.06 | $245K | โ0.1% | CEO | |
Oct 20, 2026 | UTHR | Sell | 117 | $546.84 | $64K | โ0.0% | CEO | |
Oct 20, 2026 | UTHR | Sell | 320 | $557.12 | $178K | โ0.1% | CEO | |
Oct 20, 2026 | UTHR | Sell | 520 | $558.72 | $291K | โ0.2% | CEO | |
Oct 20, 2026 | UTHR | Sell | 280 | $559.70 | $157K | โ0.1% | CEO | |
Oct 20, 2026 | UTHR | Sell | 315 | $560.67 | $177K | โ0.1% | CEO | |
Oct 20, 2026 | UTHR | Sell | 360 | $561.84 | $202K | โ0.1% | CEO | |
Oct 20, 2026 | UTHR | Sell | 464 | $562.78 | $261K | โ0.1% | CEO | |
Oct 20, 2026 | UTHR | Sell | 221 | $563.56 | $125K | โ0.1% | CEO | |
Oct 20, 2026 | UTHR | Sell | 160 | $555.09 | $89K | โ0.0% | CEO | |
Oct 20, 2026 | UTHR | Sell | 1,260 | $553.97 | $698K | โ0.4% | CEO | |
Oct 20, 2026 | UTHR | Sell | 240 | $553.14 | $133K | โ0.1% | CEO | |
Oct 20, 2026 | UTHR | Sell | 1,560 | $551.85 | $861K | โ0.5% | CEO | |
Oct 20, 2026 | UTHR | Sell | 1,134 | $551.03 | $625K | โ0.3% | CEO | |
Oct 20, 2026 | UTHR | Sell | 586 | $550.02 | $322K | โ0.2% | CEO | |
Oct 14, 2026 | UTHR | Sell | 633 | $537.19 | $340K | โ0.2% | CEO | |
Oct 14, 2026 | UTHR | Sell | 525 | $539.09 | $283K | โ0.2% | CEO | |
Oct 14, 2026 | UTHR | Sell | 2,002 | $540.23 | $1.1M | โ0.6% | CEO | |
Oct 14, 2026 | UTHR | Sell | 1,930 | $541.20 | $1.0M | โ0.6% | CEO | |
Oct 14, 2026 | UTHR | Sell | 883 | $542.07 | $479K | โ0.3% | CEO | |
Oct 14, 2026 | UTHR | Sell | 480 | $544.35 | $261K | โ0.1% | CEO | |
Oct 14, 2026 | UTHR | Sell | 40 | $526.07 | $21K | โ0.0% | CEO | |
Oct 14, 2026 | UTHR | Sell | 160 | $530.09 | $85K | โ0.0% | CEO | |
Oct 14, 2026 | UTHR | Sell | 120 | $531.19 | $64K | โ0.0% | CEO | |
Oct 14, 2026 | UTHR | Sell | 240 | $534.63 | $128K | โ0.1% | CEO | |
Oct 14, 2026 | UTHR | Sell | 400 | $535.89 | $214K | โ0.1% | CEO | |
Oct 14, 2026 | UTHR | Sell | 1,127 | $538.00 | $606K | โ0.3% | CEO | |
Oct 13, 2026 | UTHR | Sell | 160 | $550.59 | $88K | โ0.0% | CEO | |
Oct 13, 2026 | UTHR | Sell | 80 | $551.49 | $44K | โ0.0% | CEO | |
Oct 13, 2026 | UTHR | Sell | 2,340 | $543.48 | $1.3M | โ0.7% | CEO | |
Oct 13, 2026 | UTHR | Sell | 1,492 | $544.56 | $812K | โ0.5% | CEO | |
Oct 13, 2026 | UTHR | Sell | 1,507 | $545.52 | $822K | โ0.5% | CEO | |
Oct 13, 2026 | UTHR | Sell | 1,452 | $546.46 | $793K | โ0.4% | CEO | |
Oct 13, 2026 | UTHR | Sell | 630 | $547.47 | $345K | โ0.2% | CEO |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| UTHR | UNITED THERAPEUTICS Corp | 1,154 | $572.5M |
Other insiders at UNITED THERAPEUTICS Corp
9 other tracked filers at UTHR.